Chronic Lymphocytic Leukemia
What is Chronic Lymphocytic Leukemia?
Chronic Lymphocytic Leukemia (CLL) is a cancer of the lymphocytes, which are a type of white blood cells. It is a blood disorder in which there is an increased number of white blood cells in lymphoid tissues.
| Name | Description |
|---|---|
| mmagsi | Chronic Lymphocytic Leukemia is a difficult disorder to cope with. Patients are suggested to stay healthy and clean. They should do all they can to avoid infections, go to all of their appointments, and reduce the chance of second cancers (by not smoking and drinking alcohol) Emotional support should be given by family for going through treatment can be overwhelming. Physical activities, a good nutrition, and resting are important factors to improve the well-being of the patient. Open conversations about concerns and fears are also helpful. Counselling and medications may aid with emotional distress. |
Chronic Lymphocytic Leukemia community discussions will be posted here.
There are no new discussions. Start one now!!
Clinical Trials
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
- Complete the screening form.
- Review the informed consent.
- Answer the permission and data sharing questions.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Community Leaders
Expert Questions
Ask a question
Community User List
I have been off IVIG since February. For now I am on Singulair and an ACE inhibitor. I have been having minor attacks but have been able to stay out of the hospital.
...
Start a Community
Don't See Your Condition On Rareshare?
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
FAQ
Have questions about rareshare?
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Discussion Forum
Chronic Lymphocytic Leukemia community discussions will be posted here.
There are no new discussions. Start one now!!
Our Communities
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITY
Our Resources
Our rare disease resources include e-books and podcasts
Our Community Leaders
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.